SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ArQule, Inc. Plunges as Japanese Partner Temporarily Suspends Tivantinib Trial; Stock Down -1.3101 (19.55%) @ 1:19 PM EDT